Pharmaceutical Drug Delivery Market - By Route Of Administration (Oral, Injectable, Self-Injectors, Topical, Pulmonary, Nasal, Transmucosal), By Application, Facility Of Use (Hospitals, Clinics, Home Care Settings, Diagnostic Centers) - Global Forecast to 2032

Pharmaceutical Drug Delivery Market Size

Pharmaceutical Drug Delivery Market size was more than USD 1.6 trillion in 2022 and is forecast to observe more than 7% CAGR from 2023 to 2032. The rising adoption of self-administration and home care will influence the market development.
 

Emerging preferences for self-administration and at-home care will influence the market trends. A large portion of the elderly population is preferring home care over hospital care as it is a more affordable and practical option. The high prevalence of many diseases and an increase in the number of diabetic patients worldwide has resulted in the widespread usage of self-injector devices for the administration of insulin. As patients are choosing self-administration devices to eliminate the high costs of hospitalization and caregivers, many companies are launching new drug delivery products to meet the impending demand. For instance, in May 2022, Jabil Healthcare launched the Qfinity Autoinjector Platform which is a reusable drug delivery device.
 

Concerns over needlestick injuries could hamper the growth of the pharmaceutical drug delivery market. Injuries from needlesticks happen when a needle inadvertently pierces the skin. Such wounds are dangerous because they can spread bacteria that can result in deadly bloodborne diseases. As per estimates, around 600,000 to 800,000 needlestick injuries are recorded in the US each year. Healthcare workers are at high risk of needlestick injuries which can lead to serious or fatal infections.
 

Pharmaceutical Drug Delivery Market Analysis

Pharmaceutical drug delivery market share from the injectable segment is expected to witness a 7.4% CAGR from 2023 to 2032. There are two types of injectable drug delivery systems: traditional and self-injecting. These devices have gained popularity during the COVID-19 pandemic for making vaccines and is continued to be used to treat conditions like diabetes, cancer, and cardiovascular disease. With the rising number of chronic diseases, the demand for these products will increase worldwide. Pharmaceutical companies are actively expanding their manufacturing capacity to boost the production of injectable drug delivery products. For instance, in October 2022, Eisai launched a new injectable drug delivery facility worth USD 69 million. The company built a research building for the development of new products in the segment.
 

Pharmaceutical drug delivery market share from the infectious diseases segment is predicted to reach more than USD 555 billion by 2032. Worldwide, the prevalence of infectious diseases including SARS, swine flu, TB, and others is rising. Oral or injectable drug delivery techniques are majorly used for the effective treatment of infectious disorders. Climate change and viruses like COVID-19 are increasing the burden of healthcare infrastructure, driving the need for effective drug delivery solutions. As per the CDC, the West Nile virus, Lyme disease, and valley fever are a few examples of infectious diseases that have spread over the years.
 

Pharmaceutical drug delivery market share from the hospitals segment is expected to reach over USD 1.8 trillion by 2032. This growth will be accelerated by the large patient population visiting hospitals for a range of diseases. Hospitals also provide a wide range of medical services to patients, which accelerates market growth. The advanced infrastructure and medical devices present in hospitals attract more patients. The development of cutting-edge technologies and the presence of highly skilled professionals will influence market growth over the coming years.
 

North America pharmaceutical drug delivery market share was nearly 49% in 2022. Alcohol consumption, smoking, and sedentary behavior are all contributing to an increase in cases of diseases, which will support market expansion. Additionally, the region is home to a significant number of well-known pharmaceutical brands. Multiple hospitals and other healthcare facilities are in abundance in the region. Furthermore, high healthcare expenditures and expanding government initiatives to support improvement in healthcare sector is expected to endorse pharmaceutical drug delivery companies in the region.
 

Pharmaceutical Drug Delivery Market Share

• Johnson & Johnson
• AstraZeneca plc
• AbbVie Inc
• Bayer AG
• Amgen Inc
• Eli Lilly and Company
• Sanofi
• Merck & Co Inc.
• GILEAD SCIENCES, INC.,
• Pfizer Inc.

are some of the key players in the global pharmaceutical drug delivery market. Initiatives by the companies like partnerships, collaborations, and new product launches are expected to increase market growth over the years. For instance, in March 2023, Sanofi reduced the cost of their popular insulin Lantus by 78% with a cap of USD 35 in order to make the out-of-pocket drugs more affordable for all patients with commercial insurance.
 

The pharmaceutical drug delivery market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Route of Administration

• Oral drug delivery
  • Solid oral drugs
    • Tablets
    • Capsules
    • Powders
    • Pills
  • Liquid oral drugs
    • Syrups
    • Solutions
  • Semi solid oral drugs                    
    • Gels      
    • Emulsions          
    • Elixirs    
• Injectable drug delivery
  • Conventional injection devices                
    • By material        
      • Glass syringes
      • Plastic syringes
    • By Product        
      • Fillable syringes
      • Prefilled syringes
    • By Usability       
      • Reusable syringes
      • Disposable syringes
  • Self-injection devices
    • Needle-free injectors    
    • Autoinjectors    
    • Pen injectors     
    • Wearable injectors        
  • Other injector devices
• Topical drug delivery                                   
  • Liquid formulations                      
    • Solutions            
    • Suspensions      
  • Semi-solid formulations                             
    • Creams
    • Gels      
    • Ointments         
    • Pastes  
    • Lotions
  • Solid formulations                        
    • Suppositories    
    • Powders             
  • Transdermal products                 
    • Transdermal patches    
    • Transdermal gels            
• Ocular drug delivery                                    
  • Liquid formulations                      
    • Eye drops           
    • Liquid sprays     
  • Semisolid formulations               
    • Gels      
    • Eye ointments  
  • Ocular devices                 
    • Drug-coated contact lenses        
    • Ocular inserts   
• Pulmonary drug delivery                                           
  • Metered-dose inhalers                
  • Dry powder inhalers                     
  • Nebulizers                         
    • Jet nebulizers    
    • Ultrasonic nebulizers     
    • Soft mist nebulizers       
• Nasal drug delivery                                      
  • Nasal drops                      
  • Nasal sprays                     
  • Nasal powders                
  • Nasal gels                         
• Transmucosal drug delivery                                     
  • Oral formulations                          
    • Buccal drug delivery      
    • Sublingual drug delivery              
  • Other transmucosal drug delivery technologies
    • Rectal drug delivery                      
    • Vaginal drug delivery                   
• Implantable drug delivery
  • Active implantable drug delivery            
  • Passive implantable drug delivery

By Application

• Infectious diseases
• Cancer 
• Cardiovascular  diseases
• Diabetes
• Respiratory diseases      
• Central nervous system disorders
• Autoimmune diseases
• Other applications         

By Facility of Use

• Hospitals
• Ambulatory surgical centers and clinics
• Home care settings
• Diagnostic centers
• Other facilities of use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Switzerland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa